Inflammatory bowel disease (IBD) is characterized by chronic remitting and relapsing inflammation of the lower gastrointestinal tract. The etiology underlying IBD remains unknown, but it is thought to involve a hypersensitive immune response to environmental antigens, including the microbiota. Diagnosis and monitoring of IBD is heavily reliant on endoscopy, which is invasive and does not provide information regarding specific mediators. This review describes recent developments in imaging of IBD with a focus on positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of inflammatory mediators, and how these developments may be applied to the microbiota
The use of cross-sectional imaging and ultrasonography has long complemented endoscopic assessment o...
Clinical scores, serum and faecal markers, and endoscopy all have limitations in their use as instru...
Optical enhancement technologies are emerging as promising tools to improve diagnosis and clinical m...
Inflammatory bowel disease (IBD) is characterized by chronic remitting and relapsing inflammation of...
Published: 21 August 2018Inflammatory bowel disease (IBD) is characterized by chronic remitting and ...
Inflammatory bowel diseases (IBD) are a group of pathological conditions characterized by chronic in...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are represented by ulcerative colitis and Crohn's disease, both consisti...
Inflammatory bowel diseases are represented by ulcerative colitis and Crohn's disease, both consisti...
To present the current state-of-the art of molecular imaging in the management of patients affected ...
Background: Different invasive and non-invasive imaging modalities are indispensable tools in the ...
Use: PET scanning with fluorine-18–labelled fluorodeoxyglu-cose ([18F]FDG) measures regional glucose...
The use of cross-sectional imaging and ultrasonography has long complemented endoscopic assessment o...
Clinical scores, serum and faecal markers, and endoscopy all have limitations in their use as instru...
Optical enhancement technologies are emerging as promising tools to improve diagnosis and clinical m...
Inflammatory bowel disease (IBD) is characterized by chronic remitting and relapsing inflammation of...
Published: 21 August 2018Inflammatory bowel disease (IBD) is characterized by chronic remitting and ...
Inflammatory bowel diseases (IBD) are a group of pathological conditions characterized by chronic in...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are lifelong disorders affecting the gastrointestinal tract characterize...
Inflammatory bowel diseases are represented by ulcerative colitis and Crohn's disease, both consisti...
Inflammatory bowel diseases are represented by ulcerative colitis and Crohn's disease, both consisti...
To present the current state-of-the art of molecular imaging in the management of patients affected ...
Background: Different invasive and non-invasive imaging modalities are indispensable tools in the ...
Use: PET scanning with fluorine-18–labelled fluorodeoxyglu-cose ([18F]FDG) measures regional glucose...
The use of cross-sectional imaging and ultrasonography has long complemented endoscopic assessment o...
Clinical scores, serum and faecal markers, and endoscopy all have limitations in their use as instru...
Optical enhancement technologies are emerging as promising tools to improve diagnosis and clinical m...